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Differential regulation of the µ-opioid receptor (MOP) has been linked to the development
of opioid tolerance and dependence which both limit the clinical use of opioid analgesics.
At a cellular level, MOP regulation occurs via receptor phosphorylation, desensitization,
plasma membrane redistribution, and internalization. Here, we used fluorescence
correlation spectroscopy (FCS) and fluorescence recovery after photobleaching (FRAP)
to detect and quantify ligand-dependent changes in the plasma membrane organization
of MOP expressed in human embryonic kidney (HEK293) cells. The low internalizing
agonist morphine and the antagonist naloxone did not alter constitutive MOP plasma
membrane organization. In contrast, the internalizing agonist DAMGO changed MOP
plasma membrane organization in a pertussis toxin-insensitive manner and by two
mechanisms. Firstly, it slowed MOP diffusion in a manner that was independent of
internalization but dependent on GRK2/3. Secondly, DAMGO reduced the surface
receptor number and the proportion of mobile receptors, and increased receptor
clustering in a manner that was dependent on clathrin-mediated endocytosis. Overall,
these results suggest the existence of distinct sequential MOP reorganization events at
the plasma membrane and provide insights into the specific protein interactions that
control MOP plasma membrane organization.
Keywords: G protein-coupled receptor, µ-opioid receptor, G protein-coupled receptor kinase, plasma membrane,
fluorescence correlation spectroscopy, fluorescence recovery after photobleaching
Summary Statement
G protein-coupled receptor kinase modulates µ-opioid receptor micro-diffusion at the plasma
membrane prior to internalization.
INTRODUCTION
The µ-opioid receptor (MOP) is the GPCR that mediates the analgesic effects of opioids
such as morphine, fentanyl, and codeine. Despite being the mainstay analgesics for the
treatment of acute pain, prolonged opioid use in inflammatory and chronic pain is severely
limited by on-target adverse effects including tolerance and dependence. Furthermore, opioid
prescription, abuse and overdose deaths have reached record levels globally (Rudd et al., 2016;
Abbreviations: AC, autocorrelation; ANOVA, analysis of variance; DAMGO, (D-Ala2,N-Me-Phe4,Gly5-ol)-enkephalin;
FCS, fluorescence correlation spectroscopy; FRAP, fluorescence recovery after photobleaching; GPCR, G protein-coupled
receptor; GRK, GPCR kinase; HEK, human embryonic kidney; MOP, µ-opioid receptor; PCH, photon counting histogram;
PTx, pertussis toxin.
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Floyd and Warren, 2018), and the development of safer and
more effective analgesics remains an unmet medical challenge.
Differential regulation of MOP by morphine compared to other
synthetic opioids or opioid peptides, has been linked to its
increased propensity for tolerance and dependence (Duttaroy
and Yoburn, 1995; Morgan and Christie, 2011; Williams et al.,
2013); a better understanding of the molecular mechanisms
governing MOP regulation is an important step in improving the
therapeutic profiles of opioid analgesics.
As with other GPCRs, MOP-mediated signaling is initiated
at the plasma membrane via protein–protein interactions
between the receptor and its effectors. More recently,
compartmentalization of GPCRs and their effectors within
distinct subcellular locations or micro-domains of the plasma
membrane has been shown to play a key role in their signaling
(Sungkaworn et al., 2017; Eichel et al., 2018; Yanagawa et al.,
2018). The concept that this may dictate specific cellular
responses is particularly relevant in the context of MOP
signaling, since MOP activation by different agonists results
in distinct regulation and downstream signaling responses.
For instance, the peptide agonist DAMGO causes multi-
site phosphorylation of the receptor mediated by GRK2/3,
inducing robust β-arrestin recruitment, and internalization. In
contrast, the alkaloid agonist morphine causes limited receptor
phosphorylation, and weak internalization (Doll et al., 2011;
Lau et al., 2011; Just et al., 2013; Miess et al., 2018). MOP has
been demonstrated to partition into lipid rafts and the dynamics
of MOP diffusion at the plasma membrane contribute to the
specific signaling responses elicited by different opioid ligands
(Huang et al., 2007; Gaibelet et al., 2008; Zheng et al., 2008).
For instance, the distribution of opioid receptors, including the
MOP, into different nanoscale plasma membrane domains has
been shown to be influenced by cholesterol (Rogacki et al., 2018),
and MOP mobility, surface density, and the dynamics of plasma
membrane lipids is affected by ethanol (Vukojevic et al., 2008b).
Lateral mobility of MOP and MOP-G protein coupling is also
changed differentially by the activating agonist (Sauliere-Nzeh
Ndong et al., 2010) in a manner depending on the membrane
cholesterol content (Melkes et al., 2016). Together, these studies
suggest a link between distinct functional states of MOP and the
dynamic organization of receptors within the plasma membrane.
In addition, we have previously reported that DAMGO and
morphine elicit different spatiotemporal signaling profiles, and
that these are dictated by the lateral redistribution of MOP
within the plasma membrane, rather than internalization (Halls
et al., 2016). However, these previous studies lacked the temporal
resolution required to investigate rapid diffusion changes of the
receptor at the cell surface.
Live cell imaging techniques such as FCS and FRAP can
provide greater temporal resolution to determine ligand-
mediated changes in MOP dynamics and organization at the
membrane. FCS is a highly sensitive confocal technique that
can be used to quantify the diffusion and number of fluorescent
species in small areas of living cells (Diekmann and Hoischen,
2014; Briddon et al., 2018). In FCS, fluorescent particles
are excited as they pass through a small, defined confocal
volume (∼0.2 fL) leading to time-dependent fluctuations
in the detected fluorescence intensity; statistical analysis
of these fluctuations using AC or PCH analysis allows
the concentration and diffusion of fluorescent proteins
to be determined in a small defined area (∼0.2 µm2) of
the plasma membrane. FRAP can be used in conjunction
with FCS to measure diffusion properties over a larger
membrane area and give an indication of the proportion of
mobile and immobile proteins (Haustein and Schwille, 2004;
Pucadyil et al., 2007).
Here, we investigate the effect of different ligands on the
organization and dynamics of MOP at the plasma membrane.
Using FCS we quantify changes in the movement (diffusion
coefficient; DFCS), number (particle number; N), and clustering
(molecular brightness; ε) of a fluorescently labeled SNAP-
tagged MOP within small micro-domains of the membrane.
Additionally, we use FRAP to determine the diffusion coefficient
(DFRAP) and proportion of mobile (MF) receptors over a larger
membrane area. We show that the internalizing agonist DAMGO
slowed MOP diffusion in a time- and concentration-dependent
manner, increased receptor clustering and the proportion of
immobile MOP and reduced surface receptor number in a PTx
-insensitive manner. These effects were not observed with the
antagonist naloxone or the low internalizing agonist morphine.
Notably, we were able to delineate the decrease in lateral mobility
of MOP in response to DAMGO, which was dependent on
GRK2/3 activity, from the clustering and decrease in MOP
receptor number, which was dependent on clathrin-dependent
endocytosis. These data provide insight into the role of GRKs as
agonist-specific regulators of MOP micro-diffusion.
RESULTS
Basal Plasma Membrane Organization of
SNAP-MOP Detected by FCS and FRAP
To study the organization of MOP within living cell membranes,
we performed FCS measurements on HEK293 cells stably
expressing N-terminally SNAP-tagged human MOP (SNAP-
MOP). Addition of the SNAP-tag at the N-terminus of the
MOP did not alter its function, as shown by the ability of
both DAMGO and morphine to inhibit forskolin-induced cAMP
production in a similar way to the FLAG-tagged MOP (pEC50s:
DAMGO = 7.67± 0.26 and 8.11± 0.08; morphine = 7.79± 0.31
and 7.92 ± 0.32 FLAG-MOP and SNAP-MOP, respectively,
n = 4; Supplementary Figures 1A,B). Use of a SNAP-MOP
fusion allowed specific labeling of cell surface MOP using a cell
membrane impermeable SNAP-Surface R© 488 (BG-488) dye that
specifically and covalently binds to SNAP-tagged proteins present
at the cell surface.
Fluorescence correlation spectroscopy measurements were
performed on SNAP-MOP cells by positioning the confocal
volume in x-y over the cell cytoplasm, and subsequently
on the upper membrane at the peak intensity of a z scan
(Figure 1A). FCS fluorescence fluctuation traces were recorded
for 30s. The AC analysis yielded a two-component curve,
consisting of a fast-diffusing component (τD1; 10–15% of
amplitude) indicative of residual free SNAP label with the
remainder a slow component (τD2) representing diffusion of
the SNAP-MOP (see section “Materials and Methods”). The
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FIGURE 1 | Basal plasma membrane organization of MOP detected by FCS and FRAP. (A) FCS measurement volume was positioned on the upper membrane
using a live confocal image (1) and an intensity scan in z (2). (3) Schematic representation of FCS measurements on the membrane of HEK293 SNAP-MOP cells
labeled with SNAP-Surface 488 (BG-488) dye. (B) Representative fluctuation trace in basal conditions for autocorrelation (AC) analysis in which fluctuations in
intensity (δI) from the intensity mean (<I>) are calculated at two time points (t and t+τ) for all t and a range of τ values to generate an AC function that provides the
(Continued)
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FIGURE 1 | Continued
average dwell time (τD) and particle number (N). τD1 represents the average dwell time of free BG-488 and was set to 32 µs; τD2 represents the average dwell time
of BG-488 bound to SNAP-MOP from which the receptor diffusion coefficient (DFCS; µm2/s) was calculated. N represents the number of particles and was used to
calculate surface particle concentration (N/µm2). (C) Representative fluctuation trace in basal conditions and subsequent PCH analysis in which the amplitude of the
fluctuations can be analyzed by quantifying the photons in defined time bins (100 µs). Super-Poissonian statistical analysis of the resulting frequency histogram
allows the molecular brightness (ε) of SNAP-MOP containing particles to be determined. Two representative cell measurements under basal conditions are shown
with the fit (solid red line) to one component (black squares) or two components (gray squares) accordingly. The poor 1 component fit (dotted red line) for the cell
trace represented in gray squares is also shown. (D) Schematic representation of FRAP method and representative image of a cell in basal conditions during the
bleaching protocol. Fluorescence recovery average trace of SNAP-MOP in basal conditions that provides a half-time (τ1/2) from which the diffusion coefficient
(DFRAP; µm2/s), and mobile and immobile fractions (MF and IF, respectively) are inferred.
FIGURE 2 | Fluorescence correlation spectroscopy measurements in HEK293 SNAP-MOP cells following ligand stimulation. (A) Representative images from
HEK293 SNAP-MOP cells labeled with SNAP-Surface 488 (BG-488) dye after stimulation with vehicle, 30 µM morphine or 10 µM DAMGO for 20 min. Scale bar
10 µm; arrows represent agonist-induced internalization. (B) Representative FCS traces from single HEK293 SNAP-MOP cells after stimulation with vehicle, 30 µM
morphine, or 10 µM DAMGO for 20 min (gray area indicates the initial 5 s of data that were removed, see section “Materials and Methods”), and their corresponding
AC fit indicating N and τD of SNAP-MOP. (C) Diffusion coefficient of SNAP-MOP upon stimulation with 30 µM naloxone, 30 µM morphine, 10 µM DAMGO (20 min,
37◦C), or 10 µM DAMGO after pre-treatment with 30 µM naloxone (30 min, 37◦C) (n = 25–107 cells from 5 to 23 independent experiments; one-way ANOVA,
F (df1,df2): F (4,416) = 15.04, P < 0.0001). (D) Particle number of SNAP-MOP upon stimulation with 30 µM naloxone, 30 µM morphine, 10 µM DAMGO (20 min,
37◦C), or 10 µM DAMGO after pre-treatment with 30 µM naloxone (30 min, 37◦C) (n = 25–107 cells from a minimum of 5 independent experiments;
F (4,416) = 11.06, P < 0.0001). (E) Molecular brightness of SNAP-MOP after stimulation with 30 µM naloxone, 30 µM morphine, 10 µM DAMGO, or 10 µM DAMGO
after pre-treatment with 30 µM naloxone. For each condition, brightness values for the first (left) and second (right) component are shown [n = 30–126 cells from a
minimum of 6 independent experiments; F (4,82) = 5.74, P < 0.0001], with the percentage of cells requiring a two-component fit annotated. (F) Diffusion coefficient
of SNAP-MOP upon increasing concentration of morphine or DAMGO after 20 min incubation [n = 14–18 cells from 3 independent experiments; F (7,110) = 4.14,
P < 0.0001]. (G) Diffusion coefficient of SNAP-MOP upon stimulation with 30 µM morphine or 10 µM DAMGO with increasing time incubation periods [n = 15 from
3 independent experiments; F (7,113) = 4.36, P = 0.0003]. Each data point on the scatter plots represents a measurement from an individual cell (number of cells in
parenthesis) and column plots represent mean ± SEM of the indicated number of cells. ∗ denotes significance vs. vehicle treatment and ∧ denotes significance vs.
DAMGO control in one-way ANOVA with Sidak’s multiple comparisons test (∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001, ∗∗∗∗P < 0.0001, ∧∧P < 0.01).
average dwell time (τD2) and particle number (N) of the SNAP-
MOP within the detection volume were obtained from the AC
curve, from which the diffusion coefficient (DFCS; µm2/s), and
receptor density (N/µm2) were calculated (Figure 1B and see
section “Materials and Methods”). These measurements showed
that under basal conditions, DFCS for the SNAP-MOP was
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0.146 ± 0.016 µm2/s with a receptor density (N) of 157 ± 19
particles/µm2 (n = 14 cells) (Figure 1B). Analysis of the same
fluorescence fluctuations using PCH analysis yielded the average
molecular brightness (ε; counts per molecule per second, kHz) of
the fluorescent species (Figure 1C and Materials and Methods),
providing an indication of the extent of SNAP-MOP clustering.
Under basal conditions PCH analysis of fluctuations from
the majority (81%) of cells fitted to a single brightness
component with an average ε of 41.7 ± 3.8 kHz (n = 21
cells) (Figure 1C). Interestingly, in 19% of the cells analyzed, a
second brighter component (average ε = 90.8 ± 14.1 kHz) was
detected (Figure 1C), indicating the presence of higher-order
oligomeric forms of SNAP-MOP in basal conditions. Of note,
the brighter component was always less abundant relative to the
single component.
In order to ensure that accurate diffusion coefficients were
obtained, excitation laser power was optimized to give a
maximum signal to noise ratio (highest ε) with minimal spot
photobleaching (indicated by no increase in DFCS or decrease
in N) (Supplementary Figure 1C). On the basis of these data,
subsequent experiments used a laser power of ∼0.08 kW/cm2.
FCS measurements were also conducted on cells labeled with
a range of BG-488 concentrations that ensured that all of the
cell surface receptors had been labeled (saturated N) whilst
minimizing the amount of free BG-488 label left after washing.
At concentrations of BG-488 above 50 nM, the particle number
(N) (Supplementary Figure 1D) and molecular brightness
(ε) remained constant (Supplementary Figure 1E), indicating
labeling of all cell surface receptors. On the basis of these data,
subsequent experiments used 200 nM BG-488 label. It was also
noted that as the concentration of BG-488 label increased, the
number of cells that required a second component for the PCH
fit also increased (Supplementary Figure 1E).
Since FCS only measures mobile receptor population, FRAP
was performed over a larger area of the lower cell membrane of
adherent cells to determine a macro diffusion coefficient (DFRAP),
as well as the proportions of mobile (MF) and immobile (IF)
receptors (Figure 1D). Using a circular bleach area with radius
of 2.2 µm (area ∼ 15 µm2), FRAP measurements showed that
under basal conditions 67 ± 4% of the receptor population
is mobile over this area with a diffusion rate (DFRAP) of
0.084 ± 0.008 µm2/s which was slower than that measured for
FCS (DFCS).
Ligand-Induced Changes in the Plasma
Membrane Organization of SNAP-MOP
The effect of ligand stimulation on SNAP-MOP membrane
organization was then assessed using FCS and FRAP. Substantial
fluorescence remained at the plasma membrane after stimulation
with saturating concentrations of the poorly internalizing agonist
morphine (30µM) or the internalizing agonist DAMGO (10µM)
for 20 min (Figure 2A). This is not surprising since we have
previously shown that DAMGO-induced internalization reached
a maximum 1 h after agonist stimulation (Halls et al., 2016; Miess
et al., 2018). We then recorded FCS fluctuation traces of SNAP-
MOP following exposure to each ligand and performed AC and
PCH analysis (Figure 2B). Stimulation with DAMGO (10 µM)
caused a significant decrease in MOP diffusion co-efficient (DFCS)
(P < 0.0001, ANOVA and post hoc Sidak’s test; n numbers
TABLE 1 | Diffusion coefficient (DFCS), particle concentration (N) and clustering measured by FCS and diffusion coefficient (DFRAP) and immobile fraction (IF) measured by
FRAP of SNAP-MOP expressing cells under different treatment conditions.
Treatment conditions FCS FRAP
DFCS (µm2/s) N (particles/µm2) Clustering (% cells) DFRAP (µm2/s) IF (%)
Vehicle 0.128 ± 0.005 175 ± 11 15 ± 3 0.084 ± 0.008 34 ± 3
Naloxone 0.145 ± 0.009 245 ± 17∗∗ 13 ± 7 0.089 ± 0.007 33 ± 2
Control Morphine 0.121 ± 0.006 212 ± 15 21 ± 4 0.079 ± 0.005 33 ± 3
DAMGO 0.079 ± 0.006§ 125 ± 10∗ 37 ± 4∗∗∗ 0.080 ± 0.007 52 ± 4§
DAMGO + Naloxone 0.130 ± 0.007∧∧ 219 ± 35∧∧ 7 ± 4∧∧ ND ND
Vehicle 0.132 ± 0.012 155 ± 23 20 ± 0 ND ND
PTx Naloxone 0.127 ± 0.013 241 ± 25 0 ± 0 ND ND
Morphine 0.122 ± 0.006 236 ± 20 0 ± 0 ND ND
DAMGO 0.093 ± 0.010# 170 ± 18 30 ± 13 ND ND
Vehicle 0.129 ± 0.012 112 ± 9 15 ± 6 0.105 ± 0.014 45 ± 4
Pitstop2 Morphine 0.126 ± 0.011 204 ± 19 21 ± 10 0.132 ± 0.027 24 ± 3#
DAMGO 0.082 ± 0.010# 143 ± 16 21 ± 9 0.113 ± 0.031 48 ± 4
Vehicle 0.126 ± 0.011 180 ± 19 13 ± 8 0.102 ± 0.013 40 ± 5
Cmpd101 Morphine 0.118 ± 0.010 217 ± 23 11 ± 4 0.085 ± 0.009 28 ± 3
DAMGO 0.106 ± 0.008 243 ± 26 13 ± 5 0.084 ± 0.012 30 ± 4
∗denotes significance vs. vehicle control (∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001, § P < 0.0001) in one-way ANOVA with Sidak’s multiple comparisons test. ∧∧denotes
significance vs. DAMGO control (∧∧P < 0.01) in one-way ANOVA with Sidak’s multiple comparisons test. #denotes significance vs. vehicle in the same inhibitor pre-
treatment condition (#P < 0.05) in one-way ANOVA with Sidak’s multiple comparisons test. ND, not determined. All data are shown as mean ± SEM. For clarity, n
numbers (cells and independent experiments) are referred to in the appropriate figures and their legends but are from a minimum of 5 independent experiments.
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and ANOVA parameters given in figure legends for this and
all subsequent P values) (Figure 2C and Table 1), a decrease
in particle number (N) (P = 0.032) (Figure 2D and Table 1),
and DAMGO stimulation increased the percentage of cells with
a bright second component in PCH analysis (from 15% in
vehicle to 37% in DAMGO-treated cells; P = 0.0008), suggesting
that DAMGO stimulation induces clustering of SNAP-MOP
(Figure 2E and Table 1). These changes were mediated by
receptor activation, since they were not present in cells which
were pre-treated with the MOP antagonist naloxone (10 µM)
(P = 0.001, 0.008, and 0.004 for differences in DFCS, N and
clustering in presence and absence of naloxone, respectively).
The slowing in diffusion caused by DAMGO was concentration-
(Figure 2F) and time-dependent (Figure 2G), with a significant
decrease in DFCS seen at concentrations of 1 µM and above
(P = 0.003), which is consistent with DAMGO’s potency for
recruitment of regulatory proteins (Miess et al., 2018), and
after 20 min of stimulation, which is prior to internalization
(Miess et al., 2018).
In contrast to DAMGO, stimulation with morphine (up
to 30 µM) or naloxone alone (30 µM) did not cause any
significant changes in DFCS or clustering compared to vehicle
treatment (P = 0.91 and 0.24, respectively; Figures 2C–G),
indicating that changes in MOP plasma membrane organization
are agonist-specific. Interestingly, incubation with naloxone
alone significantly increased the particle number (N) compared
to vehicle treatment (P = 0.002) (Figure 2D). This increase might
indicate that naloxone prevents constitutive MOP internalization
observed in vehicle (Figure 2A), resulting in an increase in
surface receptor number.
Since FCS can only determine the properties of mobile
receptors, we also used FRAP to assess whether ligand
stimulation changes the proportion of mobile vs. immobile
receptors (Figure 3A). Following exposure of cells to 10 µM
DAMGO, the immobile fraction (IF) of MOP was significantly
increased from 34 ± 3% in vehicle-treated cells to 52 ± 4%
in DAMGO-treated conditions (P < 0.0001) (Figure 3B). In
contrast, treatment with morphine or naloxone caused no change
in mobile fraction compared to vehicle (P = 0.99 and 0.99,
respectively). Contrary to the decrease in DFCS induced by
DAMGO, DFRAP remained unchanged upon stimulation with
any of the ligands (Figure 3C).
These data therefore suggest ligand-specific changes in MOP
membrane organization, with DAMGO stimulation slowing
MOP diffusion, reducing surface receptor number, increasing
receptor clustering, and the proportion of immobile receptors.
While these effects were reversed with naloxone, none of these
changes were observed following stimulation with morphine.
MOP Membrane Reorganization Is
Independent of Gi/o Protein Activation
The dependence of MOP reorganization on G protein activation
was then investigated using PTx as a Gαi/o inhibitor (100 ng/ml,
overnight treatment). Consistent with previous data (Halls
et al., 2016), inhibition of Gαi/o activation did not prevent
DAMGO-induced MOP internalization (Figure 4A) at a PTx
concentration that was effective at preventing agonist-induced
adenylyl cyclase inhibition (Figure 4B). However, PTx treatment
did not affect DAMGO-induced clustering (Figure 4C and
Table 1) or slowing in diffusion (Figure 4D and Table 1).
Altogether, these data suggest that G protein activation is not
necessary for the changes in MOP membrane organization
induced by DAMGO.
Effect of Internalization Inhibition on
Ligand-Induced Changes in
MOP Organization
To investigate whether the DAMGO-mediated changes in
MOP organization were dependent on MOP internalization,
we used an inhibitor of clathrin-dependent internalization,
Pitstop2 (30 µM, 30 min pre-treatment), which has previously
been shown to block DAMGO-induced MOP endocytosis
(Halls et al., 2016). In FCS experiments, Pitstop2 prevented
DAMGO-induced receptor clustering as shown by the
reduction in the percentage of cells that showed the second
brighter PCH component in the presence of the inhibitor
(P = 0.944 DAMGO/Pitstop2 vs. Pitstop2 alone) (Figure 5A).
There was also no DAMGO-mediated increase in immobile
fraction detected using FRAP in the presence of Pitstop2
(P = 0.95) (Table 1). However, inhibiting internalization
did not significantly affect the DAMGO-induced slowing in
diffusion measured by FCS (P = 0.028 DAMGO/Pitstop2
vs. Pitstop2 alone) (Figure 5B and Table 1). Altogether,
these data suggest that MOP diffuses laterally at the plasma
membrane, clustering and immobilizing in clathrin-coated pits
prior to internalization. Some MOP organization events
such as clustering are dependent on clathrin-mediated
endocytosis. However, Pitstop2 was not able to prevent
the DAMGO-induced decrease in DFCS, highlighting that
a different molecular mechanism must be underlying this
micro-diffusion event.
Effect of GRK Inhibition on
Ligand-Induced Changes in
MOP Organization
We then investigated a potential role for GRKs in MOP
reorganization since interaction with and phosphorylation
by these kinases occurs rapidly after receptor activation,
prior to internalization and in an agonist-dependent manner
(Miess et al., 2018). As expected from an event that precedes
internalization, inhibition of GRK2/3 with Cmpd101 (30 µM,
30 min pre-treatment) prevented DAMGO-induced clustering
measured with FCS ( P = 0.003 DAMGO vs. DAMGO/Cmpd101;
P > 0.999 DAMGO/Cmpd101 vs. Cmpd101 alone; Figure 5C
and Table 1) and the increase in immobile fraction detected by
FRAP (P = 0.442; Table 1). Remarkably, and unlike PitStop2,
Cmpd101 also prevented the DAMGO-induced slowing as
measured by decrease in DFCS (P = 0.550 DAMGO/Cmpd101
vs. Cmpd101 alone; Figure 5D and Table 1). Cmpd101
treatment significantly reduced GRK2-Venus recruitment
to FLAG-MOP-NLuc (Figure 5E) and phosphorylation
at one of the key C-terminal phosphorylation residues
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FIGURE 3 | Fluorescence recovery after photobleaching measurements on the lower membrane of HEK293 SNAP-MOP cells following ligand stimulation.
(A) Fluorescence recovery curves of HEK293 SNAP-MOP cells during FRAP experiments under control conditions and following stimulation with 30 µM morphine or
10 µM DAMGO for 20 min at 37◦C (n = 26–31 from 6 independent experiments). MF, mobile fraction and IF, immobile fraction. (B) Immobile fraction and (C) diffusion
coefficient of SNAP-MOP as determined by FRAP (DFRAP) analysis following stimulation with 30 µM naloxone, 30 µM morphine or 10 µM DAMGO (n = 26–31 from
6 independent experiments; one-way ANOVA, F (df1,df2): F (3,114) = 10.48, P < 0.0001). Each data point of the scatter plots represents an individual cell
measurement (number of cells in parenthesis) and column plots represent mean ± SEM of the indicated number of cells. ∗ denotes significance vs. vehicle treatment
in one-way ANOVA with Sidak’s multiple comparisons test (∗∗∗∗p < 0.0001).
FIGURE 4 | Effect of pertussis toxin (PTx) pre-treatment on SNAP-MOP function and membrane organization. HEK293 SNAP-MOP cells were exposed to PTx
(100 ng/ml overnight, 37◦C). (A) Representative images of PTx pre-treated HEK293 SNAP-MOP cells after stimulation with vehicle or 10 µM DAMGO. Scale bar
10 µm, arrows represent agonist-induced internalization. (B) Agonist-mediated inhibition of forskolin-induced cAMP accumulation upon stimulation with 10 µM
DAMGO or 10 µM morphine in control (closed bars) or PTx pre-treated cells (open bars) in a CAMYEL BRET assay. Data are shown as percentage of inhibition of
cAMP induced by 10 µM forskolin and represent mean ± SEM of 3 independent experiments (one-way ANOVA, F (df1,df2): F (3,12) = 30.17, P < 0.0001). ∧ denotes
significance vs. DAMGO or morphine in the untreated condition (∧∧∧∧P < 0.0001) with Sidak’s multiple comparisons test. (C) Molecular brightness [F (3,12) = 5.4,
P = 0.014] and (D) diffusion coefficients from FCS measurements of SNAP-MOP after stimulation with 30 µM naloxone, 30 µM morphine or 10 µM DAMGO in PTx
pre-treated cells (n = 19–20 cells from 4 independent experiments, F (7,132) = 4.59, P = 0.0001). For each condition, brightness values for the first (left) and second
(right) component are shown, with the number of cells requiring a two-component fit indicated as percentage. Each data point on the scatter plots represents a
measurement from an individual cell (number of cells in parenthesis) and column plots represent mean ± SEM of the indicated number of cells. ∗ denotes
significance vs. vehicle treatment in one-way ANOVA with Sidak’s multiple comparisons test (∗∗P < 0.01).
S375 (Figure 5F), indicating that Cmpd101 prevents both
recruitment and subsequent activity of GRK2 at the MOP. These
data suggest the existence of a GRK-dependent mechanism
(scaffolding or phosphorylation), which results in the DAMGO-
stimulated slowing in diffusion and precedes receptor clustering
and internalization.
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FIGURE 5 | Effect of internalization inhibitor Pitstop2 and GRK2/3 inhibitor Cmpd101 on SNAP-MOP membrane organization. HEK293 SNAP-MOP cells were
exposed to the internalization inhibitor Pitstop2 (30 µM, 30 min, 37◦C) or GRK2/3 inhibitor Cmpd101 (30 µM, 30 min, 37◦C). (A) Molecular brightness of
SNAP-MOP after stimulation with vehicle or 10 µM DAMGO in control or Pitstop2 pre-treated cells [n = 32–40 cells from 6 to 8 independent experiments, one-way
ANOVA, F (df1,df2): F (3,26) 2.67, P = 0.060]. (B) Diffusion coefficient of SNAP-MOP upon stimulation with vehicle or 10 µM DAMGO in control or Pitstop2
pre-treated cells [n = 26–36 from 6 to 8 independent experiments, F (3,121) = 5.00, P = 0.003]. (C) Molecular brightness of SNAP-MOP after stimulation with vehicle
or 10 µM DAMGO in control or Cmpd101 pre-treated cells [n = 36–46 cells from 6 to 8 independent experiments, F (3,28) = 4.86, P = 0.008]. (D) Diffusion coefficient
of SNAP-MOP upon stimulation with vehicle or 10 µM DAMGO in control or Cmpd101 pre-treated cells [n = 37–47 cells from 6 to 8 independent experiments,
F (3,161) = 4.15, P = 0.007]. For each condition of the molecular brightness data, brightness values for the first (left) and second (right) component are shown, with
the number of cells requiring a two-component fit indicated as percentage. Each data point on the scatter plots represents a measurement from an individual cell
(number of cells in parenthesis) and column plots represent mean ± SEM of the indicated number of cells or individual experiments. (E) HEK293 were transiently
transfected with FLAG-MOP-NLuc and GRK2-Venus to measure GRK2 recruitment in a BRET assay after stimulation with 10 µM DAMGO in control or Cmpd101
pre-treated cells (n = 3 independent experiments). The BRET ratio of vehicle-treated cells was subtracted, data represent mean ± SEM normalized to control
condition, ∧∧ denotes significance vs. DAMGO alone (P = 0.002, unpaired Student’s t-test). (F) Quantification of pS375 FLAG-MOP upon stimulation with vehicle or
1 µM DAMGO in control or Cmpd101 pre-treated cells. Phosphorylation of S375 was quantified as the ratio of anti-phosphoS375 (pS375) MOP site antibody
immunostaining divided by FLAG immunostaining and normalized to vehicle of the control condition [n = 3 independent experiments, F (3,8) = 9.348, P = 0.005].
∗ denotes significance vs. vehicle treatment and ∧ denotes significance vs. DAMGO control in one-way ANOVA with Sidak’s multiple comparisons test (ns, not
significant, P > 0.05, ∗P < 0.05, ∗∗P < 0.01, ∧P < 0.05, ∧∧P < 0.01).
DISCUSSION
The formation of highly dynamic signaling complexes at the
plasma membrane of the cell is key for the generation of
specific cellular responses to extracellular stimuli. Stimulation
of transmembrane proteins such as GPCRs can alter the
composition of these receptor-effector platforms to generate
a tailored signaling profile. This is illustrated, for example,
by the process of receptor internalization, where prolonged
stimulation of a GPCR by an agonist leads to phosphorylation
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of its intracellular domains which results in the recruitment of
a myriad of regulatory proteins (including β-arrestins, AP-2,
clathrin). These proteins facilitate receptor accumulation in
clathrin-coated pits and trafficking of the receptor to intracellular
compartments. While receptor endocytosis represents a
macroscopic change in receptor reorganization, diffusion of
adaptor proteins at the microscopic scale has been suggested to
occur prior to internalization (Rappoport et al., 2006). Recent
advances in quantitative live cell imaging techniques and receptor
labeling have been instrumental in providing further information
on these dynamic micro-changes in receptor organization that
occur at the plasma membrane prior to receptor accumulation
into intracellular compartments (Sungkaworn et al., 2017;
Yanagawa et al., 2018). In addition, such studies have also
demonstrated that effector proteins such as adenylyl cyclase
redistribute and reorganize their micro-environment to generate
highly specialized signaling hubs (Ayling et al., 2012).
Understanding such microdomain level diffusion events is
of particular relevance for the MOP, since activation of MOP
by different ligands results in distinct regulatory profiles. While
endogenous opioid peptides and their analogs induce robust
receptor internalization, other opioid ligands such as morphine
are very weak at driving MOP internalization (Keith et al., 1996;
Whistler and von Zastrow, 1998). Moreover, we have recently
shown that differential activation of MOP also results in distinct
spatiotemporal signaling profiles that are controlled by a change
in distribution of the receptor within the plasma membrane
(Halls et al., 2016). Here, we have used complementary imaging
techniques (FCS and FRAP) to gain further understanding of
the changes in plasma membrane MOP distribution that occur
following receptor activation with DAMGO (an enkephalin
derivative that causes robust MOP internalization) compared to
morphine (a poor internalizing agonist).
Our data shows that only DAMGO, but not morphine,
can change the lateral organization of the MOP from basal
conditions in a concentration and time-dependent manner, prior
to its movement to clathrin-coated pits and internalization.
We detected significant DAMGO-induced slowing in diffusion
at 1 µM after 20 min of stimulation, a time point at which
internalization is minimal (Halls et al., 2016). For this reason,
we anticipate that this slowing in diffusion alludes to an event
prior to receptor endocytosis. DAMGO-induced reorganization
occurs at two different levels; there is a micro-reorganization
event (reflected in changes in the diffusion coefficient) and
macro-reorganization event (which changes surface receptor
number, clustering and immobile fraction). Differences between
micro- and macro-level MOP organization were also illustrated
by the slower MOP diffusion co-efficient determined by FRAP
compared to FCS. This can be interpreted as a free local diffusion
within a confined domain, but restricted movement across larger
distances. Notably, DAMGO-induced changes were only seen
in DFCS, but not in DFRAP, consisting with a local change
in organization.
Additionally, we showed that the plasma membrane
reorganization induced by DAMGO is independent of G protein
activation and that the “macro” changes in MOP clustering are
mediated by clathrin-dependent endocytosis. Interestingly, the
initial slowing of the MOP was only prevented by Cmpd101,
a GRK2/3 inhibitor, but was independent of (or occurs prior
to) clathrin-mediated endocytosis. This suggests that the large-
scale changes induced by internalization such as the decrease
in particle number and the increase in molecular brightness
represent clustering into coated pits where the receptor is
immobilized within the clathrin lattice. We propose that a rapid
reorganization event that involves a decrease of the diffusion of
MOP occurs at the plasma membrane prior to internalization.
Such lateral reorganization requires GRK2 and is likely to be
responsible for the distinct agonist-specific signaling patterns
that we have previously observed (as per Halls et al., 2016).
This reorganization is followed by larger scale movements of
the MOP into clathrin-coated pits resulting in clustering and
endocytosis (Figure 6).
DAMGO-induced slowing in MOP diffusion could be
caused by a change in the molecular composition of the
receptor complex (i.e., direct interaction with GRKs, although
interaction with other phosphorylation-dependent proteins
cannot be dismissed) soon after receptor activation and prior
to its accumulation in clathrin-coated pits. A change in the
composition of the MOP complex on this timescale would
be consistent with our previous observations of a DAMGO-
induced receptor redistribution to control transient activation
of cytosolic and nuclear ERK (Halls et al., 2016). Therefore, not
only is the differential recruitment of GRK2/3 by DAMGO vs.
morphine important for MOP regulation (Miess et al., 2018),
it also plays an essential role in MOP diffusion events that
facilitate activation of compartmentalized signaling, revealing
a novel role of GRKs as agonist-specific regulators of MOP
plasma membrane signaling. On that note, GRKs are typically
recognized for their catalytic activity in mediating agonist-
induced phosphorylation of GPCRs that eventually result in
receptor internalization. Importantly, scaffolding roles for GRKs
have also been described in which the kinase participates in the
generation of a macromolecular signalosomes in a manner that
can be independent of its kinase activity (Penela et al., 2010).
The mechanism underlying this GRK-dependent micro-diffusion
event of MOP remains to be elucidated and future studies should
investigate whether it is the kinase or the scaffolding function
of GRK2 that is required for the observed changes in plasma
membrane reorganization of MOP.
Several studies have shown the complexity of MOP dynamics
within the plasma membrane. Recent FCS and PALM studies
have provided unprecedented details on the dynamic lateral
organization of MOP and KOP. These studies have shown
that in unstimulated cells, GFP tagged receptors are organized
into nano-domains that partially overlap with cholesterol-rich
domains and are excluded from GM1-ganglioside-enriched
domains (Rogacki et al., 2018). However, this study did not
report on the changes that may occur upon receptor stimulation.
Previous FRAP studies using a GFP-MOP have investigated
the lateral diffusion of MOP upon DAMGO and morphine
stimulation (Sauliere-Nzeh Ndong et al., 2010). While morphine
seemed to induce limited diffusion, with small domain size
and diffusion coefficient, DAMGO displayed bigger changes in
diffusion range in addition to the effects observed with morphine.
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FIGURE 6 | GRK2 mediates MOP micro-diffusion events that precede internalization. Agonist stimulation of SNAP-MOP with morphine does not alter its constitutive
plasma membrane organization. In contrast, agonist stimulation with DAMGO causes re-organization of SNAP-MOP indicated by the decrease in diffusion coefficient
(DFCS), the decrease in particle concentration (N), the increase in molecular brightness (ε), and the increase in immobile fraction (IF). G protein activation is not
involved in SNAP-MOP plasma membrane organization, whereas GRK2/3 activity mediates DAMGO-induced slowing in DFCS independent or prior to clustering and
movement of SNAP-MOP into clathrin-coated pits to proceed toward internalization. The latter events are responsible for changes in macro-scale parameters such
as the reduced N, increased ε and IF.
Interestingly, these latter long-range changes were absent when
receptor endocytosis was inhibited, and the small-range changes
seemed to be dependent on G protein activation. Although
we did not observe changes in FRAP diffusion coefficients,
our FRAP data, showing that upon treatment with Pitstop2
the immobile receptor fraction of DAMGO-activated MOP is
not different than vehicle, is in line with these observations.
A second FRAP study has shown ligand-dependent changes
in the diffusion rate of MOP that are differentially affected
by cholesterol depletion (Melkes et al., 2016). Such divergent
results concerning the influence of agonists on the diffusion
coefficients of MOP can, be attributed to different experimental
conditions including the use of different fusion proteins. The
attachment of a fluorescent protein tag to the receptor does
not allow to distinguish between receptors that are already
at the cell surface at the time of stimulation and newly
synthesized receptors that are subsequently incorporated into
the plasma membrane from the intracellular compartment,
thus properties from different receptor pools might have been
incorporated. Moreover, addition of the fluorescent protein
within the C-terminus could interfere with complex formation
and could affect the diffusion rates measured.
Experimental and computational evidence has also
highlighted that the membrane organization of MOP can
be influenced by changes in lipid content (Vukojevic et al., 2008a;
Marino et al., 2016). Cholesterol has been shown to promote
MOP homodimerization (Zheng et al., 2012), agonist binding
(Gaibelet et al., 2008), coupling with G proteins (Gaibelet et al.,
2008; Zheng et al., 2012), and translocation of β-arrestin (Qiu
et al., 2011). Such movement between membrane domains with
different lipid composition (e.g., cholesterol/non-cholesterol)
could account for the slowing in MOP diffusion induced by
DAMGO although further experiments should address the role
of GRKs in this event. Nevertheless, this provides a potential
mechanism by which the direct interaction of lipids with the
receptor or the membrane micro-environment can facilitate
interactions with specific signaling effectors and account for the
agonist-specific spatiotemporal signaling elicited by the MOP (as
per Halls et al., 2016).
In summary, we have described here that the plasma
membrane reorganization of MOP at the micro scale level
is dependent on GRK2/3 and at the macro scale level is
dependent on clathrin-dependent internalization. This study
therefore reveals an important and novel role of GRKs in
modulating plasma membrane MOP organization; and provides
evidence that the lateral diffusion of MOP represents a molecular
event, distinct and prior to internalization, that is differentially
regulated by opioids and controls its spatiotemporal signaling.
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MATERIALS AND METHODS
Reagents
D-Ala2,N-Me-Phe4,Gly5-ol-enkephalin was obtained from
Mimotopes. Morphine, Rhodamine 6G and M2-anti-FLAG were
from Sigma-Aldrich (Gillingham, Dorset, United Kingdom).
Naloxone was from Tocris. SNAP-Surface 488 was from New
England Biolabs (Ipswich, MA, United States). The antibody anti-
pS375 was from Cell Signaling. Secondary antibodies (raised in
donkey) conjugated to Alexa-Fluor 488 or 647 were from Jackson
ImmunoResearch. Coelenterazine h was from NanoLight.
Furimazine was from Promega. Compound 101 was from
HelloBio. Pitstop2 was from Abcam. PTx was from Millipore.
Plasmids
To create the SNAP-MOP constructs, the full coding sequence for
the human MOP (hMOP) was ligated into a pcDNA3.1(+) vector
containing the 5-HT3 receptor membrane localization signal
sequence and the SNAP-tag (New England Biolabs, Ipswich, MA,
United States) (Gherbi et al., 2015) and a neomycin resistance
gene. Initial site-directed mutagenesis was required to remove
the internal BamHI site in the MOP receptor while maintaining
the amino acid sequence. Additional site-directed mutagenesis
was performed to mutate the start codon (Met to Leu) on the
MOP cDNAs. These were then ligated to the C-terminus of
SNAP using BamHI and XhoI restriction enzymes. The resulting
fusion protein contained a Gly-Ser linker between the SNAP open
reading frame (ORF) and the MOP ORF.
To create the FLAG-MOP-NLuc, the NLuc sequence (Soave
et al., 2016) was ligated immediately after the C-terminus of
FLAG-mMOP cDNA without stop codon (Miess et al., 2018) with
XhoI and XbaI restriction enzymes in a pcDNA3.1 vector. All
sequences were confirmed by DNA sequencing.
GRK2-Venus was from D. Jensen (Columbia University,
New York), CAMYEL sensor has been previously characterized
(Jiang et al., 2007).
Generation of Cell Lines
Human embryonic kidney cells (ATCC, Middlesex,
United Kingdom) were grown in Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 10% (v/v)
fetal calf serum and maintained at 37◦C in a humidified
incubator containing 5% CO2. Cells were transfected with
the pcDNA3.1+ vector containing SNAP-MOP constructs
using Fugene HD (Promega) as transfection reagent according
to the manufacturer’s instructions. Twenty-four hours post
transfection, the medium was supplemented with 1 mg/ml
G418-selective pressure for 2 weeks for the generation of stable
mixed population HEK293 SNAP-hMOP cell line.
Cell Plating and Treatments
Stable mixed population cell lines were plated onto poly-
D-lysine–coated 8-well Labtek No.1 borosilicate chambered
coverglasses (Nunc Nalgene International, Thermo Fisher
Scientific). On the day of the experiment, SNAP tag labeling
was performed by incubating cells with 200 nM (or as
otherwise indicated) SNAP-Surface 488 (BG-488) dye in fresh
cell culture media for 30 min at 37◦C. Cells were washed in
pre-warmed HEPES-buffered saline solution (HBSS; Briddon
et al., 2004) containing 4.5 mM D-glucose and pretreated
with inhibitors for 30 min at 37◦C, except for pertussis
toxin (PTx; 16 h pre-treatment). Inhibitors were used at the
following concentrations: 30 µM Pitstop2, 30 µM Cmpd101,
or 100 ng/ml PTx. Cells were then stimulated for 20 min (or
as otherwise indicated) at 37◦C with vehicle (0.3% v/v DMSO),
10 µM DAMGO, 30 µM morphine, 30 µM naloxone, or
10 µM DAMGO after pre-treatment for 30 min at 37◦C with
30 µM naloxone.
Fluorescence Correlation
Spectroscopy (FCS)
Cells were equilibrated to room temperature (22 ± 2◦C) to
minimize artifacts from temperature-induced plasma membrane
fluctuations. FCS measurements were taken at room temperature
on a Zeiss LSM510NLO Confocor 3 inverted confocal microscope
using a 40× c-Apochromat 1.2 NA water-immersion objective
(Carl Zeiss, Jena, Germany) as previously described (Ayling et al.,
2012). The confocal volume was calibrated on the day of each
experiment using 20 nM Rhodamine 6G (R6G; D = 2.8 × 10−10
m2/s). The measurement volume was positioned in x and y over
a flat portion of a healthy cell using a live confocal image, then
approximately on the upper membrane in z. Precise z-positioning
on the upper plasma membrane peak was performed using
an intensity z-scan at 0.25 µm intervals for ±2 µm. Samples
were excited using a 488 nm argon laser with power set to
∼0.08 kW/cm2 as measured at the objective. Fluorescence
fluctuations were then collected through a BP505-610IR emission
filter for 1× 30 s.
Autocorrelation and PCH analysis were performed using
Zen2010 Black software (Carl Zeiss, Jena, Germany). The
dimensions and volume of the detection volume as well as the
structure parameter (ratio of volume height to diameter) were
determined from a calibration FCS read using 20 nM Rhodamine
6G, fitted to a single 3D diffusion component with a triplet state
pre-exponential, as previously described (Briddon et al., 2004).
Prior to AC/PCH analysis, the initial 5–10 s of data were removed
where bleaching was present (indicated by a rapid decrease in
the average count rate) in order to ensure that AC functions
reached an asymptote at G(0) = 1. Average MOP dwell times
(τD) and particle number (N) were obtained from fitting of AC
curves to a two-component diffusion model incorporating a pre-
exponential component to account for fluorophore triple state
(as per Ayling et al., 2012). This model consisted of a three-
dimensional component (τD1) to account for the diffusion in
solution of free SNAP BG-488 label, and a two-dimensional
component (τD2) to account for the plasma membrane diffusion
of the BG-488-labeled SNAP-MOP itself (Figure 1B). The average
dwell time of free BG-488 (τD1) was fixed to 32 µs in the
fitting process, having been measured directly using 20nM BG-
488 in HBSS. The structure parameter was also fixed to the
value determined in the calibration fit. All other parameters were
allowed to vary in the fitting process. Free BG-488 concentration
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(% τD1 contribution to the AC amplitude was consistently
between 10 and 15% of the total amplitude).
Average dwell time of the SNAP-MOP allowed calculation
of the MOP diffusion coefficient (DFCS) using the equation
D = ω02/4.τD, where ω0 was the radius of the beam waist
of the detection volume determined from the calibration data
and τD was the average dwell time of SNAP-MOP in the
volume as determined from the AC analysis. Particle number
(N) was determined as the fractional contribution of the SNAP-
MOP diffusing component (τD2) multiplied by the total particle
number (N) as determined by the G(0) value of the fit of the
AC curve. This was subsequently expressed in particles per µm2
(N/µm2), by normalizing to the area of the detection volume as
projected onto a flat 2D membrane (N/piω02).
Molecular brightness (ε) was determined using PCH analysis
of the same fluctuation data. For PCH, the first-order correction
was obtained from fitting of the R6G calibration data binned at
20 µs, and fixed to this value in subsequent fitting. Data from
SNAP-MOP cells were fitted using a bin time of 100 µs. Data
were fitted to either a one or two component PCH based on the
goodness of fit at high photon counts per bin, visualized on a
linear-log scale (Figure 1C).
Fluorescence Recovery After
Photobleaching (FRAP)
Fluorescence recovery after photobleaching measurements were
performed at room temperature on a Zeiss LSM510NLO
Confocor 3 inverted confocal microscope using a 40×
c-Apochromat 1.2 NA water-immersion objective using the
Zeiss AIM3.5 software (Carl Zeiss, Jena, Germany). After
manually focusing on the basal membrane of SNAP-MOP
HEK293 cells, images were scanned using 488 nm excitation,
with emission collected through a BP505-610IR filter, with
pinhole set at 1 Airy unit and gain and offset adjusted to fit the
linear response of the PMT detectors. Images (512 × 512 pixels)
were acquired continually with no averaging on zoom 2 at a rate
of∼1 frame/second. Ten pre-bleach frames were acquired before
bleaching (100 ms, 100% power during 30 iterations) a circular
ROI of 2.14 µm radius (area = 14.8 µm2) and fluorescence
recovery was followed for a further 120 s.
Data were analyzed using the FRAP Wizard in Zen2010
Black software (Carl Zeiss, Germany). Fluorescence intensity
within the bleached ROI of the bottom membrane was
quantified over the time course of the experiment. This was
background corrected using a similar sized ROI in an area
of the image containing no cell and for bleaching during
scanning using an ROI in a non-bleached cell. Pre-bleach
frames were averaged and used as a baseline to normalize
all post-bleach frames. Recovery curves were fitted to a
simple exponential recovery curve to obtain a half time of
recovery (t1/2) and a recovery plateau (Figure 1D). The mobile
fraction (MF) is defined as the intensity of this plateau as
a percentage of the pre-bleach control, whilst the immobile
fraction (IF) is the percentage difference between intensity of
the recovery plateau and the pre-bleach intensity. Diffusion
coefficient (DFRAP) was calculated by using the equation
D = ω2/4.τ1/2, where ω (µm) is the radius of the bleached
area and τ1/2 (s) is the half-time recovery from the fitted
curve in Zen2010.
Bioluminescence Resonance Energy
Transfer (BRET)
Human embryonic kidney cells were transiently transfected
in a 10 cm dish. For CAMYEL, cells were transfected with
2.5 µg of SNAP-MOP and 2.5 µg of CAMYEL biosensor.
For GRK2 recruitment assay, cells were transfected with
1 µg FLAG-MOP-NLuc and 4 µg GRK2-Venus. After
24 h, cells were re-plated into poly-D-lysine-coated white
opaque 96-well plates (CulturPlate, PerkinElmer) and
allowed to adhere overnight. BRET experiments were
performed 48 h post-transfection. Cells were washed with
HBSS and equilibrated for 30 min at 37◦C prior to the
experiment. Coelenterazine or Furimazine was added to a final
concentration of 5 µM before dual fluorescence/luminescence
measurement in a LUMIstar Omega plate reader (BMG
LabTech). The BRET signal was calculated as the ratio
of light emitted at 530 nm by Venus over the light
emitted at 430 nm by Renilla luciferase 8 (RLuc8) or Nano
luciferase (NLuc).
For CAMYEL assays, vehicle or DAMGO (at the
indicated concentration) was added to control or PTx-
pretreated cells for 10 min and baseline was measured
for 4 cycles, then 10 µM forskolin was added to induce
cAMP production, and the BRET signal was measured
for 30 min. CAMYEL concentration response curve was
constructed with the data point at 10min after cAMP
stimulation by forskolin. Data were normalized to 0%
inhibition (forskolin-induced cAMP production) and
100% inhibition (vehicle only without forskolin-induced
cAMP production).
For GRK2 recruitment kinetic experiments, the baseline BRET
ratio was measured for 4 cycles, then either vehicle (0.01% v/v
DMSO) or 10 µM DAMGO was added to control or Cmpd101-
pretreated cells, and the BRET signal was measured for 30 min.
Anti-pS375 Immunocytochemistry
Human embryonic kidney cells transiently expressing FLAG-
MOP were grown in a 96-well clear bottom plate (PerkinElmer).
Cells were serum starved for at least 30 min and then incubated
with vehicle or an EC50 concentration of DAMGO (1 µM) at
37◦C for 5 min. Cells were then fixed in −30◦C methanol for
10 min on ice. Antigen retrieval buffer was then applied, cells
were heated in PBS supplemented with 10mM sodium citrate
and 0.05% Tween-20 (pH 6.0) at 95◦C for 20 min. Cells were
then washed in PBS and incubated in blocking solution, 10%
goat serum in PBS at room temperature for 30 min. Anti-FLAG
mouse antibody and anti-phospho S375 rabbit antibody were
diluted in blocking solution (1:1000 and 1:200, respectively) and
added to cells for incubation overnight at room temperature.
Cells were washed with PBS and incubated with AlexaFluor
488 (AF488) anti-mouse IgG and AlexaFluor 647 (AF647)
anti-rabbit goat IgG secondary antibodies (1:1000 in blocking
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solution) at room temperature for 1h. Cells were washed and
imaged on the Operetta High Content Imaging System capturing
AF488 and AF647 channels using a 20× objective. The mean
fluorescence intensity of each channel was quantified from the
raw 16-bit images using the Operetta analysis software and
levels of phosphorylation were expressed as a ratio of pS375
(AF647)/FLAG (AF488) immunostaining and normalized to
vehicle treatment in control conditions.
Statistical Analysis
Data representation and statistical analysis were performed using
GraphPad Prism v7. FRAP and FCS data are presented as
the mean ± SEM from ‘n’ individual cells, with the number
of independent experiments also stated. For statistical analysis
of clustering from PCH data, the data are represented as the
mean ± SEM of the % of cells requiring a two-component fit
in each independent experiment. The BRET data was quantified
as indicated and represent the mean ± SEM of at least three
individual experiments. Statistical significance was determined
by either unpaired Student’s t-test or one-way ANOVA with
post hoc Sidak’s multiple comparison analysis. P values for
the post hoc tests are given in the text, whilst details of
one-way ANOVA parameters are given in the relevant figure
and table legends.
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